F-group (family)
4019.1.1.3 Transpeptidase
Ligands and drugs
1,279
Member domains
1,017
with ligand contacts (≤ 4 Å)
79.5% of members
904
with DrugDomain annotations
70.7% of members
349
with a DrugBank compound
27.3% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 4019.1.1.3 belongs to X-group 4019 alpha-helical domain in beta-lactamase/transpeptidase-like proteins, which binds 8.4 ligand superclasses per 20 proteins, broader than 65% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB09157 | CO2 | Carbon dioxide | 20 |
| DB08375 | CEF | (2R)-2-[(1R)-1-[[(2Z)-2-(2-Amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-2-oxoethyl]-5-methylidene-2H-1,3-thiazine-4-carboxylic acid | 17 |
| DB02145 | 1BO | Butyl alcohol | 13 |
| DB03530 | CAZ | Acylated ceftazidime | 6 |
| DB00355 | AZR | Aztreonam | 5 |
| DB03658 | AXL | (2R,4S)-2-[(1R)-1-{[(2R)-2-Amino-2-(4-hydroxyphenyl)acetyl]amino}-2-oxoethyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid | 4 |
| DB09459 | TLA | L-tartaric acid | 3 |
| DB02122 | IAP | 4-iodo-acetamido phenylboronic acid | 2 |
| DB02676 | B3P | 2-[3-(2-Hydroxy-1,1-Dihydroxymethyl-Ethylamino)-Propylamino]-2-Hydroxymethyl-Propane-1,3-Diol | 2 |
| DB03450 | CEP | Cephalothin Group | 2 |
| DB03766 | PPI | Propanoic acid | 2 |
| DB04640 | BIH | Naphthalene-2,6-disulfonic acid | 2 |
| DB04740 | MX1 | Moxalactam (hydrolyzed) | 2 |
| DB08508 | S2D | N-BENZOYL-D-ALANINE | 2 |
| DB12107 | 4D6 | Vaborbactam | 2 |
| DB16338 | KJK | Taniborbactam | 2 |
| DB02175 | MLA | Malonic acid | 1 |
| DB02219 | CXS | 3-(cyclohexylamino)propanesulfonic acid | 1 |
| DB02249 | ETX | 2-Ethoxyethanol | 1 |
| DB02536 | 3GR | D-glyceraldehyde | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| CL | CHLORIDE ION | 119 |
| NXL | (2S,5R)-1-formyl-5-[(sulfooxy)amino]piperidine-2-carboxamide | 61 |
| CDmetal | CADMIUM ION | 34 |
| MER | (4R,5S)-3-{[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl}-5-[(2S,3R)-3-hydroxy-1-oxobutan-2-yl]-4-methyl-4,5-dihydro-1H-pyrrole-2-carboxylic acid | 27 |
| NAmetal | SODIUM ION | 25 |
| Y33 | (5R)-3-{[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl}-5-[(2S,3R)-3-hydroxy-1-oxobutan-2-yl]-5-methyl-4,5-dihydro-1H-pyrrole-2-carboxylic acid | 25 |
| IM2 | (5R)-5-[(1S,2R)-1-formyl-2-hydroxypropyl]-3-[(2-{[(E)-iminomethyl]amino}ethyl)sulfanyl]-4,5-dihydro-1H-pyrrole-2-carboxylic acid | 23 |
| CO2 | CARBON DIOXIDE | 22 |
| ID1 | Imipenem | 22 |
| PNM | OPEN FORM - PENICILLIN G | 20 |
| 1BO | 1-BUTANOL | 18 |
| BR | BROMIDE ION | 17 |
| CEF | CEFOTAXIME, C3' cleaved, open, bound form | 16 |
| ZNmetal | ZINC ION | 15 |
| IOD | IODIDE ION | 14 |
| MGmetal | MAGNESIUM ION | 13 |
| 2RG | (2S,3R,4S)-4-({(3S,5S)-5-[(3-carboxyphenyl)carbamoyl]pyrrolidin-3-yl}sulfanyl)-2-[(1S,2R)-1-formyl-2-hydroxypropyl]-3-methyl-3,4-dihydro-2H-pyrrole-5-carboxylic acid | 12 |
| CAmetal | CALCIUM ION | 11 |
| JPP | Piperacillin (Open Form) | 11 |
| DWZ | (2S,3R,4S)-4-{[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl}-2-[(2S,3R)-3-hydroxy-1-oxobutan-2-yl]-3-methyl-3,4-dihydro-2H-pyrrole-5-carboxylic acid | 10 |